Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 13, 2020, Precision BioSciences, Inc. (the "Company") held its annual meeting of stockholders. A total of 42,147,567 shares of the Company's common stock were present in person or represented by proxy at the meeting, representing approximately 81.97% of the Company's common stock outstanding as of the March 23, 2020 record date. Following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on March 27, 2020.

Item 1 - Election of three Class I directors to serve until the Company's annual meeting of stockholders to be held in 2023 and until their respective successors have been duly elected and qualified.





                               Votes FOR        Votes WITHHELD       Broker Non-Votes
    Geno Germano                35,328,962           136,066              6,682,539
    Matthew Kane                25,507,655          9,957,373             6,682,539
    Raymond Schinazi, Ph.D.     28,811,126          6,653,902             6,682,539




Item 2 - Ratification of the appointment of Deloitte & Touche LLP as the
Company's independent registered public accounting firm for the year ending
December 31, 2020.



         Votes FOR        Votes AGAINST       Votes ABSTAINED      Broker Non-Votes
          41,047,861           28,896             1,070,810              N/A

Based on the foregoing votes, Geno Germano, Matthew Kane, and Raymond Schinazi, Ph.D. were elected as Class I directors, and Item 2 was approved.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses